Maravai LifeSciences Holdings Inc
NASDAQ:MRVI

Watchlist Manager
Maravai LifeSciences Holdings Inc Logo
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Watchlist
Price: 5.62 USD 6.24%
Market Cap: 1.4B USD
Have any thoughts about
Maravai LifeSciences Holdings Inc?
Write Note

Maravai LifeSciences Holdings Inc
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maravai LifeSciences Holdings Inc
Total Other Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Total Other Income
$667.5m
CAGR 3-Years
1 783%
CAGR 5-Years
482%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Total Other Income
-$29m
CAGR 3-Years
50%
CAGR 5-Years
N/A
CAGR 10-Years
8%
Danaher Corp
NYSE:DHR
Total Other Income
$1m
CAGR 3-Years
-75%
CAGR 5-Years
-47%
CAGR 10-Years
-43%
Mettler-Toledo International Inc
NYSE:MTD
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Agilent Technologies Inc
NYSE:A
Total Other Income
$38m
CAGR 3-Years
22%
CAGR 5-Years
20%
CAGR 10-Years
N/A
IQVIA Holdings Inc
NYSE:IQV
Total Other Income
$59m
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
18%
No Stocks Found

Maravai LifeSciences Holdings Inc
Glance View

Market Cap
1.4B USD
Industry
Life Sciences Tools & Services

Maravai Lifesciences Holdings, Inc. is a life sciences company. The company is headquartered in San Diego, California and currently employs 470 full-time employees. The company went IPO on 2020-11-20. The firm provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The firm's segments include Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. The company also provides research products for labeling and detecting proteins in cells and tissue samples. Its products include CleanCap, messenger ribonucleic acid (mRNA) and oligonucleotide. The Biologics Safety Testing focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing spectrum. The firm provides ultra-pure nucleotides to customers in the diagnostics, pharma, genomics and research markets.

MRVI Intrinsic Value
3.57 USD
Overvaluation 36%
Intrinsic Value
Price

See Also

What is Maravai LifeSciences Holdings Inc's Total Other Income?
Total Other Income
667.5m USD

Based on the financial report for Dec 31, 2023, Maravai LifeSciences Holdings Inc's Total Other Income amounts to 667.5m USD.

What is Maravai LifeSciences Holdings Inc's Total Other Income growth rate?
Total Other Income CAGR 5Y
482%

The average annual Total Other Income growth rates for Maravai LifeSciences Holdings Inc have been 1 783% over the past three years , 482% over the past five years .

Back to Top